Download - WHOCC
Download - WHOCC
Download - WHOCC
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Gonadotropins, plain and in combination with estrogens and progestogens, should<br />
be classified in this group.<br />
QG03GA<br />
Gonadotropins<br />
Naturally occurring gonad-stimulating hormones should be classified in this group.<br />
This group comprises both naturally occurring gonad-stimulating hormones and<br />
synthetic ovulation stimulants. The combination of Follicle Stimulating Hormone<br />
and Luteinizing Hormone is classified in QG03GA30.<br />
QG03GB<br />
Ovulation stimulants, synthetic<br />
QG03H<br />
QG03HA<br />
ANTIANDROGENS<br />
Antiandrogens, plain<br />
Finasteride used for treatment of benign prostatic hypertrophy is classified in<br />
QG04CB.<br />
QG03HB<br />
Antiandrogens and estrogens<br />
This group comprises all combinations of cyproterone and estrogen regardless of<br />
indication.<br />
QG03X<br />
OTHER SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM<br />
Substances modifying the genital functions, which cannot be assigned to any of the<br />
preceding groups, should be classified in this group.<br />
QG03XA<br />
QG03XB<br />
QG03XC<br />
Antigonadotropins and similar agents<br />
Antiprogestogens<br />
Selective estrogen receptor modulators<br />
QG04<br />
UROLOGICALS<br />
Antiseptic and atiinfective preparations for systemic use specifically used in urinary<br />
tract infections, see group QJ. General antiinfectives for systemic use are classified<br />
in group QJ - Antiinfectives for systemic use. Gynecological antiinfectives and<br />
antiseptics, see QG01.<br />
78
Change language